Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,708 million for the first quarter of 2014, a 19 percent increase from the same period in 2013. First quarter total revenue increased 18 percent to $1,730 million compared to $1,465 million in the first quarter of 2013. Adjusted net income for the first quarter of 2014 increased 19 percent to $705 million compared to $592 million in the first quarter of 2013. For the same period, adjusted diluted earnings per share increased 22 percent to $1.67 from $1.37.
Help employers find you! Check out all the jobs and post your resume.
